Changes in Executive Management in Lundbeck
· Kåre Schultz has resigned from his position as President and CEO to join Teva Pharmaceutical Industries Ltd. as President and CEO · Coincidentally, Staffan Schüberg has also resigned from his position as Chief Commercial Officer to join a privately held company as CEO · The process of finding a replacement for Kåre Schultz and Staffan Schüberg will commence immediately and both will remain in their respective positions until further notice · The Board sees no reason for changes in the strategic direction of the company Valby, Denmark, 11 September 2017 - H. Lundbeck A/S (